Dark
Light
System
Institutional Investment Manager
Cormorant Asset Management, LP
Cormorant Asset Management, LP (CIK: 0001583977) incorporated in Delaware, located at 200 Clarendon Street, Boston, MA. Institutional holdings reported to the SEC.

Institutional Holdings (2015Q4)
Portfolio Summary: 82 holdings with a total value of $835,862,000.
#
Name
Shares
Value ($)
%
Options
Notes
51 ACCELERON PHARMA INC 200,000 9,752,000 1.17%
52 MYOKARDIA INC 753,388 11,045,000 1.32%
53 BIOCRYST PHARMACEUTICALS 1,080,000 11,146,000 1.33%
54 VITAE PHARMACEUTICALS INC 623,409 11,284,000 1.35%
55 ROCKWELL MED INC 1,105,000 11,315,000 1.35%
56 ULTRAGENYX PHARMACEUTICAL INC COM 109,500 12,284,000 1.47%
57 COLLEGIUM PHARMACEUTICAL INC COM 450,000 12,375,000 1.48%
58 DEXCOM INC 153,000 12,531,000 1.50%
59 NEKTAR THERAPEUTICS COM 765,156 12,893,000 1.54%
60 COHERUS BIOSCIENCES INC COM 569,130 13,067,000 1.56%
61 NOVAVAX INC COM 1,600,000 13,424,000 1.61%
62 DYNAVAX TECHNOLOGIES CORP 575,000 13,892,000 1.66%
63 CELLECTIS S A 469,145 14,558,000 1.74%
64 TESARO INCORPORATED 291,250 15,238,000 1.82%
65 MACROGENICS INC 500,000 15,485,000 1.85%
66 MIRATI THERAPEUTICS INC COM 495,356 15,653,000 1.87%
67 CHINA BIOLOGIC PRODS INC 111,500 15,884,000 1.90%
68 ACLARIS THERAPEUTICS INC COM 647,944 17,456,000 2.09%
69 NEVRO CORP COM 265,386 17,916,000 2.14%
70 SORRENTO THERAPEUTICS INC COM NEW 2,095,334 18,250,000 2.18%
71 SAGE THERAPEUTICS INC 315,000 18,365,000 2.20%
72 ALNYLAM PHARMACEUTICALS INC 245,000 23,064,000 2.76%
73 QUOTIENT LTD 1,519,100 24,306,000 2.91%
74 ALDER BIOPHARMACEUTICALS INC 757,475 25,019,000 2.99%
75 PORTOLA PHARMACEUTICALS INC 500,000 25,725,000 3.08%
76 ARDELYX INC COM 1,481,075 26,837,000 3.21%
77 OMEROS CORP 1,960,000 30,831,000 3.69%
78 NEUROCRINE BIOSCIE COM USD0.001 603,900 34,163,000 4.09%
79 EAGLE PHARMACEUTICALS INC COM 400,000 35,468,000 4.24%
80 HERON THERAPEUTICS INC COM 1,685,719 45,009,000 5.38%
81 DYAX CORP COM CVR 1,400,000 52,668,000 6.30%
82 ALKERMES PLC 700,000 55,566,000 6.65%
Page 2 of 2

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-16-053224, filed 2016.02.16).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.